BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24909917)

  • 41. Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy.
    Lee JK; Lee DH; Sun EG; Bae JA; Lim SC; Min JJ; Sung MW; Kim KK
    Yonsei Med J; 2011 May; 52(3):463-8. PubMed ID: 21488189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.
    Qin J; Wang F; Jiang H; Xu J; Jiang Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(2):1328-40. PubMed ID: 25973017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
    Lin Y; Chen Z; Lin S; Zheng Y; Liu Y; Gao J; Chen S
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):598-606. PubMed ID: 31058289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
    Jin Y; Cheng H; Cao J; Shen W
    J Cell Biochem; 2019 Nov; 120(11):18629-18639. PubMed ID: 31338872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel miR-206/hnRNPA1/PKM2 axis reshapes the Warburg effect to suppress colon cancer growth.
    Fu R; Yang P; Amin S; Li Z
    Biochem Biophys Res Commun; 2020 Oct; 531(4):465-471. PubMed ID: 32800545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
    Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
    BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of microRNA-98 inhibits cell proliferation and promotes cell apoptosis via claudin-1 in human colorectal carcinoma.
    Zheng YF; Luo J; Gan GL; Li W
    J Cell Biochem; 2019 Apr; 120(4):6090-6105. PubMed ID: 30506722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway.
    Yuan W; Guo YQ; Li XY; Deng MZ; Shen ZH; Bo CB; Dai YF; Huang MY; Yang ZY; Quan YS; Tian L; Wang X
    Oncotarget; 2016 Sep; 7(37):60230-60244. PubMed ID: 27517626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A.
    Qiu Y; Yu H; Shi X; Xu K; Tang Q; Liang B; Hu S; Bao Y; Xu J; Cai J; Peng W; Cao Q; Yin P
    Cell Prolif; 2016 Feb; 49(1):69-78. PubMed ID: 26840372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2.
    Xi X; Teng M; Zhang L; Xia L; Chen J; Cui Z
    J Cell Physiol; 2020 Feb; 235(2):1330-1338. PubMed ID: 31286521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
    Yan Y; Zhang D; Lei T; Zhao C; Han J; Cui J; Wang Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):928-936. PubMed ID: 31209892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
    Yu L; Lu Y; Han X; Zhao W; Li J; Mao J; Wang B; Shen J; Fan S; Wang L; Wang M; Li L; Tang J; Song B
    Stem Cell Res Ther; 2016 Dec; 7(1):180. PubMed ID: 27906093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-497-5p mediates starvation-induced death in colon cancer cells by targeting acyl-CoA synthetase-5 and modulation of lipid metabolism.
    Gharib E; Nasri Nasrabadi P; Reza Zali M
    J Cell Physiol; 2020 Jul; 235(7-8):5570-5589. PubMed ID: 32012265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-761 inhibits colorectal cancer cell proliferation and invasion through targeting HDAC1.
    Xiong W; Yang S; Zhang W; Chen Y; Wang F
    Pharmazie; 2019 Feb; 74(2):111-114. PubMed ID: 30782261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.